Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-01 Sale | 2024-04-03 9:37 pm | Atreca Inc. | BCEL | Orwin John A PRESIDENT & CEO | 22,951 | $0.3746 | $8,597 | 77,541 (Direct) | View |
| 2022-09-02 Sale | 2022-09-20 6:12 pm | Atreca Inc. | BCEL | Orwin John A President & CEO | 20,908 | $1.7752 | $37,116 | 100,492 (Direct) | View |
| 2020-03-17 Purchase | 2020-03-19 6:52 pm | Atreca Inc. | BCEL | Orwin John A President & CEO | 6,000 | $12.79 | $76,740 | 6,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-15 Exercise | 2024-09-17 6:45 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Orwin John A Director | 1,300 | $0 | 5,935 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-18 8:15 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Orwin John A Director | 2,035 | $0 | 2,035 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:28 pm | N/A 2034-06-03 | CARGO Therapeutics Inc. | CRGX | Orwin John A Director | 23,742 | $0 | 23,742 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:06 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 26,000 | $0 | 48,375 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:57 pm | N/A 2034-01-02 | ANAPTYSBIO INC | ANAB | Orwin John A Director | 22,540 | $0 | 22,540 (Direct) | View |
| 2023-12-14 Disposition | 2023-12-15 6:10 pm | N/A 2024-01-10 | Seagen Inc. | SGEN | Orwin John A Director | 68,931 | $0 | 0 (Direct) | View |
| 2023-12-14 Disposition | 2023-12-15 6:10 pm | N/A N/A | Seagen Inc. | SGEN | Orwin John A Director | 29,003 | $229 | 0 (Direct) | View |
| 2023-11-09 Option Award | 2023-11-13 6:48 pm | N/A 2033-11-08 | CARGO Therapeutics Inc. | CRGX | Orwin John A Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2023-11-09 5:02 pm | N/A 2032-10-06 | CARGO Therapeutics Inc. | CRGX | Orwin John A Director | 0 | $0 | 137,705 (Direct) | View |
| 2023-09-15 Option Award | 2023-09-18 6:11 pm | N/A 2033-09-14 | ANAPTYSBIO INC | ANAB | Orwin John A Director | 19,846 | $0 | 19,846 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 6:21 pm | N/A N/A | Seagen Inc. | SGEN | Orwin John A Director | 2,044 | $0 | 31,047 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 18,000 | $0 | 35,875 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 9:00 pm | N/A 2033-02-08 | Atreca Inc. | BCEL | Orwin John A President & CEO | 435,000 | $0 | 535,492 (Direct) | View |
| 2022-06-13 Disposition | 2022-06-15 7:15 pm | N/A 2031-01-26 | Atreca Inc. | BCEL | Orwin John A President & CEO | 708,749 | $0 | 708,749 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 7:15 pm | N/A 2031-01-26 | Atreca Inc. | BCEL | Orwin John A President & CEO | 708,749 | $0 | 708,749 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-17 7:33 pm | 2023-05-13 2032-05-13 | Seagen Inc. | SGEN | Orwin John A Director | 5,179 | $0 | 32,679 (Direct) | View |
| 2022-05-11 Option Award | 2022-05-12 8:30 pm | 2023-05-11 2032-05-10 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 12,000 | $0 | 26,875 (Direct) | View |
| 2021-12-23 Option Award | 2021-12-28 6:50 pm | N/A 2031-12-22 | Atreca Inc. | BCEL | Orwin John A President & CEO | 260,000 | $0 | 381,400 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 9:46 pm | N/A N/A | Atreca Inc. | BCEL | Orwin John A President & CEO | 115,400 | $0 | 121,400 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 9:17 pm | 2022-05-14 2031-05-13 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 12,000 | $0 | 23,875 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 7:27 pm | 2022-05-14 2031-05-14 | Seagen Inc. | SGEN | Orwin John A Director | 4,864 | $0 | 30,962 (Direct) | View |
| 2021-01-27 Option Award | 2021-01-29 8:28 pm | N/A 2031-01-26 | Atreca Inc. | BCEL | Orwin John A President & CEO | 260,000 | $0 | 260,000 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 8:00 pm | 2021-05-15 2030-05-14 | Retrophin Inc. | RTRX | Orwin John A Director | 12,000 | $0 | 20,875 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 7:10 pm | 2021-05-15 2030-05-15 | SEATTLE GENETICS INC | SGEN | Orwin John A Director | 4,506 | $0 | 29,269 (Direct) | View |
| 2020-02-26 Option Award | 2020-02-28 5:33 pm | N/A 2030-02-25 | Atreca Inc. | BCEL | Orwin John A President & CEO | 241,000 | $0 | 241,000 (Direct) | View |